National clinical prescription audit
Audit control center
A decision-focused view of prescribing quality, safety signals and medicine affordability.
AUDIT SUMMARY · OCT 2026
Where does prescribing quality need attention?
Review medicine burden, generic use, documentation gaps and potential financial impact across the healthcare tiers represented in the dataset.
61.6%
Overall audit scoreEstimated monthly savings opportunity
₹52.6L
Modelled generic-cost scenario from the source report.
Annualised estimate₹6.3 Cr
Prescribing quality scorecard
Observed values versus source-reported reference standards
Prescription cost scenario
Current spend compared with generic-cost model
Financial burden mix
Records by reported burden category
Priority review queue
Largest signals in the source indicators
Healthcare-tier snapshot
Average medicines per prescription
Quality management
Prescribing quality
Indicator-level view and prescription documentation audit.
WHO indicator scorecard
Observed values and source-reported standards
Documentation gaps
Share documented / checked, as reported
Documentation completion detail
Prioritise low-completion safety checks for audit follow-up.
The source's benchmarks and indicator definitions are reproduced as provided. Values should be interpreted in the context of clinical setting, case mix and local policy; a threshold deviation alone does not prove inappropriate care.
Market access & affordability
Cost and access
Reported spending, modelled generic scenario and financial burden distribution.
Monthly spend bridge
Reported current spend → generic scenario → modelled difference
Financial burden distribution
Count and share reported by category
Interpretation guardrails
Price comparabilityMatch like-for-like
Verify molecule, strength, formulation, pack size and current procurement price.
Clinical suitabilityNot price alone
Generic substitution requires appropriate equivalence, availability and clinical review.
Evidence statusModelled estimate
Savings are source-derived estimates, not realised savings or patient-level economic outcomes.
Geographic comparison
Healthcare-tier comparison
Compare prescribing patterns and per-prescription cost by tier.
Average medicines & polypharmacy
Reported tier-level metrics
Average cost scenario by tier
INR per prescription
Tier-level data table
All values reproduced from the uploaded JSON
Clinical review queue
Safety worklist
Inspect source-flagged events; verify the record and clinical context before action.
Flagged prescription records
This list contains source-provided flags, not validated clinical decision support. Some source records contain duplicate or mismatched flag descriptions and incomplete medicine/condition fields. No medication changes should be made from this dashboard alone.
Utilisation review
Medicines and departments
Frequency of generic names, listed brands, dosage forms and department-level indicators.
Most frequent generic names
Counts in the uploaded source
Most listed brands
Counts in the uploaded source
Dosage-form mix
Reported medicine counts
Department snapshot
Prescription volume, cost and antibiotic rate
Top reported conditions
Condition labels and counts from source file